In addition, a study by Chen et al.260has shown that HIF‐1α upregulation in NB promotes the proliferation, invasiveness, and migration of malignant cells via SHH signaling. HIF‐1α activation also provides resistance to antiangiogenic therapies in a xenograft mouse model of NB.261. This evidence concerns the gene SHH and neuroblastoma.